BRD6257
BRD6257 is an orally active inhibitor for protein phosphatase, Mg2+/Mn2+ dependent 1D PPM1D with an IC50 of 5 nM. BRD6257 activates p53 signaling pathway with an EC50 of 51 nM, increases the p21 expression, inhibits the proliferation of cancer cell MOLM13 (IC50=2.8 μM) . BRD6257 exhibits good metabolic stability in human and rat liver microsomes[1].
Product Specifications
UNSPSC
12352005
Target
MDM-2/p53; Phosphatase
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC(F)C1=CC=C(NC([C@@H](NC2=NN3C(C=C(N=C3S2)C4=NC=C(C)O4)=O)CC5CCC(F)(C5)F)=O)C=C1
Molecular Formula
C24H22F4N6O3S
Molecular Weight
550.53
References & Citations
[1]Shaw S, et al. Identification of Small Molecule Inhibitors of PPM1D Using an Integrated Drug Discovery Platform[J]. iScience, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MAGE A1 (MA454), CF640R conjugate, 0.1mg/mL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
CD16 (C16/1045), CF405S conjugate, 0.1mg/mL
